Original communicationThorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings
Section snippets
Patients and SLN identification
Between January 1998 and January 2002, 68 female patients (median age 55 years, range 33 to 78 years) with unifocal, clinically/radiologically node-negative primary breast cancer received surgical treatment with SLN biopsy (performed by A.G.) and intraoperative pathologic examination (by W.F.G. and A.D.). The single enrollment criterion for the SLN biopsy procedure was presence of a unifocal T1 (≤2.0 cm in diameter) or small T2 (ie, 2.1 to 3.0 cm) primary breast tumor without clinical evidence
Results
Among the 68 primary tumors (median size 1.2 cm, range 0.4-2.8 cm), 6 (9%) were classified as pT1a (ie, ≤0.5 cm), 19 (28%) as pT1b (0.6 to 1.0 cm), 38 (56%) as pT1c (1.1 to 2.0 cm), and 5 (7%) as “small” pT2 (defined for the purposes of this study as 2.1 to 3.0 cm) (Table I). A single SLN was identified in 61 of 68 (90%) patients, 2 were taken in 3 (4%) patients, 3 were taken in 3 (4%) patients; and in 1 (2%) patient, 5 small radioactive nodes were taken. The maximum time taken for
Discussion
Among the methods for intraoperative evaluation of SLN in patients with small breast tumors described in the literature, the procedure proposed by Viale et al12 and Veronesi et al20 on frozen material appears to be especially reliable, with a general concordance between sentinel and axillary lymph node status of over 95%. Nevertheless, to our knowledge, reports of routine use of such an approach in other hands are currently lacking. Furthermore, according to the ADASP recommendations,22
References (34)
- et al.
Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19 to 22, 2001, Philadelphia, Pennsylvania
Hum Pathol
(2002) - et al.
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
Lancet
(1997) - et al.
Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
J Am Coll Surg
(1998) - et al.
Evaluation of feasibility and accuracy of sentinel node biopsy in early breast cancer
Am J Surg
(2001) - et al.
The sentinel node in breast cancer
N Engl J Med
(1998) - et al.
The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast
Surg Gynecol Obstet
(1981) - et al.
Improved axillary staging of breast cancer with sentinel lymphadenectomy
Ann Surg
(1995) - et al.
Sentinel lymhadenectomy in breast cancer: identification of sentinel lymph node and detection of metastases
Breast Cancer Res Treat
(1999) - et al.
Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases
Cancer
(1989) - et al.
Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients
Arch Surg
(1990)
Probability of false negative nodal status in conjunction with partial axillary dissection in breast cancer
Br J Surg
Management of axillary lymph nodes in breast cancer: a national pattern of care study of 17,151 patients
Ann Surg
Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients
Cancer
Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma
Cancer
Recommendations for sentinel lymph node processing in breast cancer
Am J Surg Pathol
Sentinel node processing
Am J Surg Pathol
Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer
Histopathology
Cited by (9)
The value of touch imprint cytology and frozen section for intra-operative evaluation of axillary sentinel lymph nodes
2010, Polish Journal of Pathology